0001672459-16-000002.txt : 20160418 0001672459-16-000002.hdr.sgml : 20160418 20160418172004 ACCESSION NUMBER: 0001672459-16-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160418 DATE AS OF CHANGE: 20160418 EFFECTIVENESS DATE: 20160418 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Colorado Therapeutics LLC CENTRAL INDEX KEY: 0001672459 IRS NUMBER: 320467434 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-261585 FILM NUMBER: 161577481 BUSINESS ADDRESS: STREET 1: 2150 WEST 6TH AVENUE STREET 2: UNIT L CITY: BROOMFIELD STATE: CO ZIP: 80020 BUSINESS PHONE: 303-469-9459 MAIL ADDRESS: STREET 1: 2150 WEST 6TH AVENUE STREET 2: UNIT L CITY: BROOMFIELD STATE: CO ZIP: 80020 D 1 primary_doc.xml X0707 D LIVE 0001672459 Colorado Therapeutics LLC 2150 WEST 6TH AVENUE UNIT L BROOMFIELD CO COLORADO 80020 303-469-9459 DELAWARE None None Limited Liability Company true 2015 Joseph Horn c/o Colorado Therapeutics LLC 2150 West 6th Ave., Unit L Broomfield CO COLORADO 80020 Director James Gleeson c/o Colorado Therapeutics LLC 2150 West 6th Ave., Unit L Broomfield CO COLORADO 80020 Director Thomas Raegan c/o Colorado Therapeutics LLC 2150 West 6th Ave., Unit L Broomfield CO COLORADO 80020 Director Eric Schabule c/o Colorado Therapeutics LLC 2150 West 6th Ave., Unit L Broomfield CO COLORADO 80020 Executive Officer Vice President of Corporate Development William Jackson c/o Colorado Therapeutics LLC 2150 West 6th Ave., Unit L Broomfield CO COLORADO 80020 Executive Officer Vice President of Regulatory Compliance & Clinical Other Technology Decline to Disclose 06b false 2015-06-11 false true false 20000 4298064 4298064 0 false 20 0 0 0 false Colorado Therapeutics LLC /s/Eric Schauble Eric Schauble Vice President 2016-04-18